N/A N=749 Optimize Low Back Pain
Low Back Pain · Chronic Pain
Primary: Change in Oswestry Disability Index From Baseline to 10 Weeks — -8.8; -6.1 Units on a scale — p=0.02
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=200 Technology Intensified Diabetes Education Study in African Americans
Diabetes Mellitus, Type 2 · Diabetes Mellitus, Adult-Onset · Diabetes Mellitus, Non-Insulin-Dependent
Primary: Hemoglobin A1c — 9.8; 9.6 mean percent of HbA1c
Phase 2 N=46 Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer
Acinar Cell Adenocarcinoma of the Pancreas · Duct Cell Adenocarcinoma of the Pancreas · Stage I Pancreatic Cancer
Primary: Progression Free Survival Rate — 67 percentage of participants
Phase 4 N=31 Comparison of Fibrinogen Concentrate and Cryoprecipitate in Pediatric Cardiac Surgery Patients
Pediatric HD · Bleeding
Primary: A Composite of the Number of Any Allogeneic Blood Products (RBCs, Plasma, Platelets, Cryoprecipitate) Transfused From Administration of the Study Medication Until 48…
N/A N=1 Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use Disorder
Opioid-Related Disorders
Primary: Safety and Tolerability as Measured by All Adverse Events Related to DBS — 3; 0; 3; 1 Adverse Events
N/A N=8 Monocyte Priming When Consuming a Western Diet
Heart Diseases
Primary: Measurement of Mitogen-activated Protein Kinase Phosphate 1 (MKP-1) Activity — 6.71 ng/mg protein
Phase 2 N=28 Bristol Bladder Trial
Infiltrating Bladder Urothelial Carcinoma
Primary: Overall Pathological Response Rate — 57.7 % of participants
Phase 4 N=20 Acute Application of Antibiotic Powder in Open Fracture Wounds
Fractures, Open · Wounds and Injuries--Infections · Anti-Bacterial Agents
Primary: Incidence of Surgical Site Infection During the Post-operative Follow-up Period — 0; 0; 0 participants
Phase 2 N=50 Dexmedetomidine Use in Infants Undergoing Cooling Due to Neonatal Encephalopathy (DICE Trial)
Hypoxic-Ischemic Encephalopathy · Pain
Primary: Examine Safety Measures in Infants Receiving DMT to Those Receiving Morphine — 1; 1 Number of serious adverse events
N/A N=35 Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study
Prostate Cancer
Primary: Feasibility - Recruitment — 39 Participants
N/A N=29 Two Way Crossover Closed Loop MPC vs Control IQ
Type 1 Diabetes
Primary: Percent of Time With Sensed Glucose Between 70-180 mg/dl — 56; 56.8 Percent (%)
N/A N=267 Phone-Based Based Walk With Ease Program for Adults With Arthritis
Arthritis · Gout · Fibromyalgia
Primary: Change in Pain — -4.0; -4.49 score on a scale
Phase 3 N=106 A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid
Bullous Pemphigoid
Primary: Percent of Participants Achieving Sustained Remission at Week 36 — 4.0; 18.2 Estimated Percentage of Participants — p=0.0250
Phase 2 N=35 Comparison of Non-Surgical Treatment Options for Chronic Exertional Compartment Syndrome (CECS)
Chronic Exertional Compartment Syndrome
Primary: University of Wisconsin Running Injury and Recovery Index Score at Baseline — 10.86; 11.86; 12.14; 9.75 cumulative score on a 9-item scale
N/A N=12 A Bioelectric Dressing for Post De-Roofing Treatment of HS
Hidradenitis Suppurativa
Primary: Healing Rate — .45; .39 cm^2/day